Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials

Guofeng Ma, Kejing Ying, Ruifeng Zhang et al.|Thrombosis Research|2015

Cited by 24